Your Psoriasis May Be Hiding in Your Genes. Here's What Your DNA Says.

Filaggrin is a structural protein that acts like mortar in the brick wall of your skin. It holds skin cells together, creates the seal that keeps water in and irritants out, and maintains the pH balance your skin needs to stay calm. Without intact filaggrin, your skin barrier develops cracks that let allergens, bacteria, and inflammatory triggers directly access the immune cells living in your skin.

The FLG variants (R501X and 2282del4) are loss-of-function mutations that impair filaggrin production. Roughly 10% of people of European ancestry carry at least one of these variants, and they have dramatically increased susceptibility to eczema and psoriasis. When your FLG is compromised, your skin barrier doesn’t just function at 80% capacity, it functions at 30-40% capacity. Irritants that would roll off intact skin in other people penetrate your skin within minutes.

You likely notice that your skin reacts to things that don’t bother other people. Fragrances, detergents, temperature changes, even tap water can trigger burning and flushing. Your skin feels tight and itchy in winter or in dry climates. You’ve probably been told you have sensitive skin. What’s actually happening is your barrier is broken at the molecular level, and that broken barrier is feeding your psoriasis by constantly exposing your immune system to triggers.

Interleukin-4 is a cytokine that tells your immune system to develop a Th2 response, which drives allergic and atopic reactions. In small amounts, it’s normal and healthy. It balances your immune system toward tolerance. In excess, it tips the scales toward chronic allergic inflammation, eczema, and enhanced psoriasis severity.

IL4 variants push your immune baseline toward stronger Th2 skewing, meaning your immune system’s default setting is allergic reactivity. Roughly 30-35% of the population carries variants that increase IL4 signaling. Your baseline production of IL4 is higher than people without these variants, which means your immune system is primed for allergic and atopic reactions from birth. This doesn’t mean you’re allergic to everything. It means your immune system’s thermostat is set a few degrees higher toward inflammation.

You probably have a history of allergies, seasonal sensitivities, or multiple food sensitivities that other people don’t experience. Your psoriasis probably flares alongside allergy season or when you’re exposed to new environments. You may have eczema in addition to psoriasis, or a strong family history of asthma and allergies. This isn’t coincidence. Your IL4 genetic profile links all of these together.

Interleukin-13 works as an amplifier in your immune system. It’s released when your immune cells detect a threat, and it tells your skin cells to pump out more inflammatory signals in response. In balanced amounts, this amplification helps you fight infection. When IL13 signaling is overactive, it turns your immune response into a megaphone, blasting inflammatory signals that trigger and perpetuate psoriasis.

IL13 variants increase production of this inflammatory amplifier, and roughly 30-35% of the population carries variants that boost IL13 signaling. People with these variants don’t just mount an immune response to triggers, they mount an exaggerated response where inflammatory signals get louder and last longer. A normal immune system recognizes a trigger, responds, and shuts down. Your IL13-boosted system recognizes a trigger, responds, amplifies, and continues amplifying for days or weeks.

You probably find that your flares persist long after the trigger is gone. You react to stress, minor cuts, insect bites, or skin irritation by developing psoriasis plaques that spread and linger. Other people shake off the same trigger. Your immune system keeps the alarm sounding long after the threat has passed. This is IL13 at work.

The vitamin D receptor is a protein that sits on immune cells and allows them to respond to vitamin D. Vitamin D isn’t just a vitamin, it’s a hormone that tells your immune system to calm down, differentiate into regulatory T-cells, and stop attacking your own tissues. Without a functional VDR, your cells can’t hear vitamin D’s anti-inflammatory message, even if your vitamin D levels are high.

VDR variants (including BsmI and FokI variants) reduce the receptor’s sensitivity or expression. Roughly 30-50% of the population carries variants that impair VDR function. People with VDR variants maintain higher inflammation even when vitamin D levels are adequate, because their immune cells simply cannot respond to vitamin D’s anti-inflammatory signals. You can take vitamin D supplements and see no improvement in your psoriasis because your immune system isn’t listening to the message.

You probably notice that vitamin D supplementation hasn’t helped your skin, or that you feel worse in winter even though you know vitamin D plays a role in immunity. You may have low vitamin D despite supplementation, or you may have adequate vitamin D levels but still experience severe psoriasis. Your VDR variants explain both patterns.

Tumor necrosis factor-alpha is one of the most potent inflammatory cytokines your immune system produces. It’s a signal that tells immune cells to attack, increases vascular permeability so inflammatory cells can enter tissue, and amplifies the entire inflammatory cascade. In controlled amounts, TNF-alpha is essential for fighting infection. In excess, it’s the primary driver of psoriasis severity.

The TNF -308G>A variant increases TNF-alpha production, and roughly 30% of the population carries the A allele. People with TNF -308A variants have baseline TNF-alpha levels that are 20-50% higher than people without the variant, meaning your inflammatory baseline is set higher from birth. You’re not reacting abnormally to triggers. Your immune system’s resting inflammatory state is elevated.

Your psoriasis is probably more severe than average, with plaques that cover larger areas or persist despite treatment. You may have a strong response to biologics that target TNF-alpha, or conversely, you may have found that standard anti-TNF treatments work beautifully while topical treatments fail completely. This genetic profile explains both patterns and predicts your response to specific therapies.

CTLA4 is the stop button on your T-cells. When activated, it tells T-cells to pause, regulate themselves, and stop proliferating. Without functional CTLA4, your T-cells lack an off switch. They activate, proliferate, and attack continuously without natural limitation. This is why CTLA4 is called the immune checkpoint, the brake that keeps autoimmune attack from running out of control.

The CTLA4 +49A>G variant reduces CTLA4 expression or function, and roughly 45% of the population carries the G allele. People with CTLA4 variants have reduced immune regulation, meaning their T-cells remain more active and harder to quiet once activated. Their immune system doesn’t just overreact to triggers, it struggles to dial back the reaction once initiated. This is the genetic basis of autoimmune skin conditions including psoriasis, lichen planus, and vitiligo.

You probably notice that your flares are hard to resolve even with anti-inflammatory treatment. Once a psoriasis plaque develops, it spreads and persists. You may also have a family history of autoimmune conditions, or you may notice that stress consistently triggers flares. This is CTLA4 at work, your immune system struggling to put on the brakes once it starts attacking.